Screening for CDKN2A mutations in hereditary melanoma.

Goldstein, A M

Screening for CDKN2A mutations in hereditary melanoma. [electronic resource] - Journal of the National Cancer Institute May 1997 - 676-8 p. digital

Publication Type: Comment; Editorial; Review

0027-8874

10.1093/jnci/89.10.676 doi


Carrier Proteins--genetics
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase Inhibitor p16
Cyclin-Dependent Kinases--antagonists & inhibitors
Enzyme Inhibitors--metabolism
Humans
Mass Screening
Melanoma--genetics
Pedigree
Polymorphism, Single-Stranded Conformational
Proto-Oncogene Proteins
Skin Neoplasms--genetics